Top

Intensive Care Medicine

Published in:

01-11-2003 | Brief Report

Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia

Authors: G. Christopher Wood, Scott D. Hanes, Bradley A. Boucher, Martin A. Croce, Timothy C. Fabian

Published in: Intensive Care Medicine | Issue 11/2003

Abstract

Objective

To report the use of tetracyclines for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP).

Design

Observational case series.

Setting

The Presley Regional Trauma Center located within the Regional Medical Center, Memphis, Tennessee, USA.

Patients and participants

Seven critically ill trauma patients with VAP caused by A. baumannii isolates that were resistant to all antibiotics tested except for doxycycline or minocycline.

Interventions

Patients were treated with IV doxycycline or minocycline for an average of 13.5 (range 9–20) days.

Measurements and results

Doxycycline or minocycline was successful in six of seven patients.

Conclusions

Doxycycline or minocycline may be effective for treating multidrug-resistant A. baumannii VAP.

American Thoracic Society (1995) Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 153:1711–1725

Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997–1999). Clin Infect Dis 32(Suppl ii):104–113CrossRef

Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA (2002) Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin Infect Dis 34:1425–1430CrossRefPubMed

Rodríguez-Hernández MJ, Pachón J, Pichardo C, Cuberos L, Ibánez-Martínez J, García-Curiel A, Caballero FJ, Moreno I, Jiménez-Mejías ME (2000) Imipenem, doxycycline and amikacin in monotherapy in combination in Acinetobacter baumannii experimental pneumonia. J Antimicrob Chemother 45:493–501CrossRefPubMed

Croce MA, Fabian TC, Waddle-Smith L, Melton SM, Minard G, Kudsk KA, Pritchard FE (1998) Utility of Gram’s stain and efficacy of quantitative cultures for posttraumatic pneumonia: A prospective study. Ann Surg 227:743–755PubMed

Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsburger H, Pitlik SD (1997) Monotherapy versus lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41:1127–1133PubMed

DuPont H, Carbon C, Carlet J (2000) Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. Antimicrob Agents Chemother 44:2028–2033CrossRefPubMed

Cometta A, Baumgartner JD, Lew D, Zimmerli W, Pittet D, Chopart P, Schaad U, Herter C, Eggimann P, Huber O, Ricou B, Suter P, Auckenthaler R, Chiolero R, bille J, Scheidegger C, Frei R, Glauser MP (1994) Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother 38:1309–1313PubMed

Croce MA, Fabian TC, Stewart RM, Pritchard FE, Minard G, Trenthem L, Kudsk KA (1993) Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients. J Trauma 35:303–311PubMed

10.

Urban C, Go E, Mariano N, Berger BJ, Avraham I, Rubin D, Rahal JJ (1993) Effect of sulbactam on infection caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 167:448–451PubMed

11.

Jiménez-Mejías ME, Pachón J, Becerril B, Palomino-Nicas J, Rodriguez-Cobacho A, Revuelta M (1997) Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin Infect Dis 24:932–935PubMed

12.

Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, Garcia-Garmendia JL, Ortiz C, Cobacho AR (1996) Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 22:1026–1032PubMed

13.

Jellison TK, McKinnon PS, Rybak MJ (2001) Epidemiology, resistance, and outcomes of Acinetobacter baumannii bactermia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 21:142–148PubMed

14.

Corbella X, Ariza J, Ardanuy C, Vuelta M, Tabau F, Sora M, Pujol M, Gudiol F (1998) Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother 42:793–802

15.

Jiménez-Mejías ME, Becerril B, Márquez-Rivas FJ, Pichardo C, Cuberos L, Pachon J (2000) Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Inf Dis 19:970–971CrossRef

16.

Wood CA, Reboli AC (1993) Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis 168:1602–1603PubMed

17.

Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA, Manrique EI, Costa SF (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011PubMed

18.

Fernandez-Viladrich P, Corbella X, Corral F, Tubau F, Mateu A (1999) Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 28:916–917PubMed

19.

Wood GC, Boucher BA (2000) Aerosolized antimicrobial therapy in acutely ill patients. Pharmacotherapy 20:166–181PubMed

20.

Wolff M, Joly-Guillou ML, Farinotti R, Carbon C (1999) In vivo efficacies of combinations of -lactams, -lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother 43:1406–1411PubMed

Title: Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia
Authors: G. Christopher Wood
Scott D. Hanes
Bradley A. Boucher
Martin A. Croce
Timothy C. Fabian
Publication date: 01-11-2003
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 11/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-003-1811-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia

Abstract

Objective

Design

Setting

Patients and participants

Interventions

Measurements and results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Setting

Patients and participants

Interventions

Measurements and results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2003

“Pond poop” from propofol

Parenteral nutrition in the critically ill

Death by parenteral nutrition

Helicobacter pylori in intensive care: why we should be interested

Early patterns of static pressure–volume loops in ARDS and their relations with PEEP-induced recruitment

Early antibiotic treatment (prophylaxis) of septic complications in severe acute necrotizing pancreatitis: a prospective, randomized, multicenter study comparing two regimens with imipenem-cilastatin